Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy
Authors
Keywords
-
Journal
BJU INTERNATIONAL
Volume 112, Issue 1, Pages 13-25
Publisher
Wiley
Online
2013-01-29
DOI
10.1111/j.1464-410x.2012.11762.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Arterial Thromboembolism in Cancer Patients Treated With Cisplatin: A Systematic Review and Meta-analysis
- (2012) Tracy Proverbs-Singh et al. JNCI-Journal of the National Cancer Institute
- Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
- (2012) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients
- (2011) Fumitaka Koga et al. BJU INTERNATIONAL
- Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience
- (2011) Jason A. Efstathiou et al. EUROPEAN UROLOGY
- Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy
- (2011) Matthew D. Galsky et al. JOURNAL OF CLINICAL ONCOLOGY
- International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
- (2011) JOURNAL OF CLINICAL ONCOLOGY
- Preliminary Results of RTOG 0233: A Phase II Randomized Trial for Muscle-invading Bladder Cancer Treated by Transurethral Resection and Radiotherapy Comparing Two Forms of Concurrent Induction Chemotherapy
- (2010) A.L. Zietman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiation Dose–Volume Effects of the Urinary Bladder
- (2010) Akila N. Viswanathan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Feasibility of Radical Transurethral Resection as Monotherapy for Selected Patients With Muscle Invasive Bladder Cancer
- (2010) Eduardo Solsona et al. JOURNAL OF UROLOGY
- Determining Factors for Hospital Discharge Status After Radical Cystectomy in a Large Contemporary Cohort
- (2010) Monty A. Aghazadeh et al. JOURNAL OF UROLOGY
- Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06
- (2009) Jason A. Efstathiou et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Study of [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Staging of Muscle-Invasive Bladder Carcinoma
- (2009) Adam S. Kibel et al. JOURNAL OF CLINICAL ONCOLOGY
- Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology
- (2008) Ahmad Shabsigh et al. EUROPEAN UROLOGY
- Techniques et innovations en radiothérapie pour le traitement conservateur des cancers infiltrants localisés de vessie
- (2008) J. Thariat et al. PROGRES EN UROLOGIE
- Long-term Results of Selective Partial Cystectomy for Invasive Urothelial Bladder Carcinoma
- (2008) Marc C. Smaldone et al. UROLOGY
- The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer
- (2008) Pantelis Hadjizacharia et al. WORLD JOURNAL OF UROLOGY
- Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties
- (2008) Toni K Choueiri et al. Nature clinical practice. Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started